- Home
- BVFL vs NBTX Comparison
BVFL vs NBTX Comparison
Compare BVFL & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- NBTX
- Stock Information
- Founded
- BVFL 1873
- NBTX 2003
- Country
- BVFL United States
- NBTX France
- Employees
- BVFL N/A
- NBTX N/A
- Industry
- BVFL Savings Institutions
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- BVFL Finance
- NBTX Health Care
- Exchange
- BVFL Nasdaq
- NBTX Nasdaq
- Market Cap
- BVFL 160.4M
- NBTX 167.8M
- IPO Year
- BVFL N/A
- NBTX 2020
- Fundamental
- Price
- BVFL $15.60
- NBTX $4.10
- Analyst Decision
- BVFL
- NBTX Strong Buy
- Analyst Count
- BVFL 0
- NBTX 1
- Target Price
- BVFL N/A
- NBTX $8.00
- AVG Volume (30 Days)
- BVFL 21.6K
- NBTX 11.2K
- Earning Date
- BVFL 07-17-2025
- NBTX 04-02-2025
- Dividend Yield
- BVFL N/A
- NBTX N/A
- EPS Growth
- BVFL N/A
- NBTX N/A
- EPS
- BVFL 1.06
- NBTX N/A
- Revenue
- BVFL $38,257,000.00
- NBTX N/A
- Revenue This Year
- BVFL N/A
- NBTX N/A
- Revenue Next Year
- BVFL N/A
- NBTX $221.06
- P/E Ratio
- BVFL $14.66
- NBTX N/A
- Revenue Growth
- BVFL 1.89
- NBTX N/A
- 52 Week Low
- BVFL $11.00
- NBTX $2.76
- 52 Week High
- BVFL $18.19
- NBTX $7.29
- Technical
- Relative Strength Index (RSI)
- BVFL 52.43
- NBTX 64.63
- Support Level
- BVFL $15.40
- NBTX $3.64
- Resistance Level
- BVFL $15.82
- NBTX $4.20
- Average True Range (ATR)
- BVFL 0.23
- NBTX 0.16
- MACD
- BVFL -0.06
- NBTX 0.04
- Stochastic Oscillator
- BVFL 36.36
- NBTX 88.51
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.